History of smoking cessation treatment in Poland – the strengthening role of cytisine as the most effective and safe pharmacotherapy

  title={History of smoking cessation treatment in Poland – the strengthening role of cytisine as the most effective and safe pharmacotherapy},
  author={Witold A. Zat{\'o}nski and Kinga Janik-Koncewicz and Zuzanna Stępnicka and Katarzyna Zatońska and Katarzyna Połtyn-Zaradna and Aleksandra Herbe{\'c}},
  journal={Journal of Health Inequalities},
One of the greatest public health successes in Poland since the 1990s has been a decline in tobacco-related morbidity and mortality, including from lung cancer and cardiovascular disease. The steady decline in smoking cigarettes among adults in Poland during this period was among the most important factors contributing to this success. The key enabling factor in this process was the increasing range and availability of different pharmacotherapy supporting smoking cessation, including nicotine… 

Figures from this paper


Cytisine—from Ethomedical use to the Development as a Natural Alternative for Smoking Cessation
The development of cytisine, nicotine—like compound, into a successful drug from natural origin used for smoking cessation showed that cytisine strictly resembles nicotine in the chemical structure, receptor binding characteristics and pharmacological effects.
An uncontrolled trial of cytisine (Tabex) for smoking cessation
The long-term abstinence rates were similar to those observed in smokers receiving nicotine replacement therapy, and full-scale randomised trials of cytisine (Tabex), conducted to the standards required by regulatory authorities, are warranted.
The place of varenicline in smoking cessation treatment
The trial by Aubin and colleagues showing that varenicline is more effective than NRT and the trials of varenICline versus bupropion mean that v Karenicline must be considered a first-line choice in smoking cessation treatment.
Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.
Since cytisine exhibits a desirable pharmacological profile which makes it an attractive smoking cessation drug, it should be advanced to randomized clinical trials, however, more detailed preclinical studies on its pharmacokinetics and safety profile are required.
The role of the Health Promotion Foundation in building capacity to treat tobacco dependence in Poland: past, present and future
The HPF’s comprehensive activities have already helped millions of Poles quit smoking and is focused on developing ways of engaging medical doctors in the treatment of tobacco dependence and the use of novel technologies in supporting effective cessation efforts, both on the side of providers and of patients.
The Polish Anti-tobacco Law – 20 years on
This issue of the Journal of Health Inequalities presents a series of articles on tobacco control in Poland and in Europe, including an outline of the history of the anti-tobacco movement in Poland, an overview of the significance and impact of the Polish anti-Tobacco legislation of 1996, an examination of the recent Polish opposition to the EU Tobacco Products Directive, a policy recommendation paper on Tobacco control measures in the Russian Federation, as well as an analysis of trends in smoking among youth.
Cytisine for nicotine addiction treatment: A review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.
The relative risks of abstinence in the efficacy analysis and RR of ARs, either reported by the authors or calculated from the reports, pooled to provide an updated meta-analysis of cytisine's efficacy and ARs for smoking cessation compared with placebo.
The significance and impact of the Polish Anti-tobacco Law
The milestone for tobacco control and health improvement was the Tobacco Control Bill passed by the Polish Sejm on 9 November 1995, and enacted in May 1996, which came as a response to the deep health crisis which engulfed Polish society by the early 1990s.
Cytisine--a tobacco treatment hiding in plain sight.
  • N. Rigotti
  • Medicine
    The New England journal of medicine
  • 2014
A randomized, controlled trial published in this issue of the Journal brings renewed attention to cytisine, a potentially useful pharmacotherapy for smoking cessation that has been hiding in plain